A UK company that makes medicines from cannabis has raised nearly $90m on New York’s Nasdaq stock exchange to develop a treatment for childhood epilepsy.
GW Pharmaceuticals already sells a marijuana-based drug across Europe as a treatment for multiple sclerosis and believes the plant’s properties have potential for use in a wider range of pharmaceutical products.
The Epilepsy Network is a worldwide community of people with epilepsy, family and friends, uniting to talk about their experiences, learn information about epilepsy, ask questions and so much more! Don’t let epilepsy defeat you, let it inspire you!
